SUBSCRIBERS
Broker's take
Published Fri, Apr 27, 2018 · 09:50 PM
TalkMed Group > Neutral RHB Securities, April 27 April 27 close: S$0.695 Target price: S$0.70
TalkMed Group reported a weak Q1 2018 . . . mainly owing to the the Singapore Medical Council's suspension of its key contributor and chief executive Ang Peng Tiam.
On the bright side, losses from associates have been reduced drastically by 60 per cent year on year, and it is expected to generate profits by end-FY2018.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Stellantis misses forecasts with 12% revenue drop in Q1, sees stronger H2
L'Occitane's billionaire owner Geiger to take firm private in US$1.8 billion deal
Australian budget airline Bonza collapses, passengers stranded
HSBC CEO to retire; bank reports 1.7% lower Q1 profit of US$10.8 billion
AIA launches wealth centre targeting high-net-worth clients
Samba, Gazelle shoes help drive Adidas sales while North America lags